
Last updated: 2026-09-16 12:10:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Amphastar Pharmaceuticals, Inc. (AMPH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $23,65, with a market capitalisation of $1,02B and a P/E ratio of 12,80. Over the past 52 weeks, its price has ranged from $16,65 to $29,52. This page covers its latest market performance, valuation, price trends and company information.
$1,02B | |
$23,75 | |
$67,66 | |
$5,00 | |
$23,91 | |
254,01K | |
478,05K | |
12,80 | |
$29,52 | |
$16,65 | |
-- | |
-- |
Amphastar Pharmaceuticals, Inc. (AMPH) is trading at $24,06 in pre-market trading as of 2026-09-15 23:31:00, up 0,63% ($0,15) from the previous close of $23,91
Pre-market trading shows how investors are pricing AMPH before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Amphastar Pharmaceuticals, Inc. (AMPH) moved from $23,18 to $23,65, representing a gain of 2,04% ($0,47).
The stock traded between $22,30 and $24,28 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 459,57 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 54,4%
AMPH is currently trading at $23,65, placing it 54,4% of the way from its 52-week low of $16,65 to its 52-week high of $29,52. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 1976 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Amphastar Pharmaceuticals, Inc. (AMPH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.